Page last updated: 2024-08-24

chlorin and Cancer of Pancreas

chlorin has been researched along with Cancer of Pancreas in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Brito, RMM; Cardoso, AL; Gomes-da-Silva, LC; Mata, AI; Nascimento, BFO; Pereira, NAM; Pineiro, M; Pinho E Melo, TMVD; Schaberle, FA1
Azzun, A; Batta-Mpouma, J; Beyzavi, H; Du, Y; Fugitt, D; Heidrick, Z; Kim, JW; McConnell, Z; Ozdemir, J; Sakamaki, Y; Salmon, C; Sinha, A; Tsuji, M; Watson, O1
Ban, T; Fujita, Y; Hayashi, K; Hayashi, N; Hori, Y; Joh, T; Kataoka, H; Kato, A; Kondo, H; Miyabe, K; Murakami, T; Naiki-Ito, A; Naitoh, I; Narumi, A; Natsume, M; Nomoto, A; Takahashi, S; Tanaka, M; Yano, S; Yoshida, M1

Other Studies

3 other study(ies) available for chlorin and Cancer of Pancreas

ArticleYear
Novel FoscanĀ®-derived ring-fused chlorins for photodynamic therapy of cancer.
    Bioorganic & medicinal chemistry, 2023, 10-01, Volume: 93

    Topics: Humans; Male; Pancreatic Neoplasms; Photochemotherapy; Porphyrins; Pyridines

2023
A Bio-Conjugated Chlorin-Based Metal-Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers.
    ACS applied bio materials, 2021, 02-15, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Humans; Molecular Structure; Nanostructures; Organometallic Compounds; Pancreatic Neoplasms; Photochemotherapy; Porphyrins; Triple Negative Breast Neoplasms

2021
Maltotriose Conjugation to a Chlorin Derivative Enhances the Antitumor Effects of Photodynamic Therapy in Peritoneal Dissemination of Pancreatic Cancer.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:6

    Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Female; Humans; Mice; Molecular Structure; Pancreatic Neoplasms; Peritoneal Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Trisaccharides; Xenograft Model Antitumor Assays

2017